Search Results

HOME > SEARCH > SEARCH RESULTS

Refine by Audience:

Your search for pilot research returned 199 results.

Selected filters: Media

Displaying 61 to 70 of 199 records
Sort by: Page: << Prev 4… 5… 6… 7… 8… 9… 10… Next >>

Translational PET Tracer Visualizes Brain Cholesterol Metabolism – Jun 25, 2023
A new PET radiotracer that visualizes the enzyme primarily responsible for metabolic cholesterol degradation in the brain has been successfully validated, according to research presented at the 2023 SNMMI Annual Meeting.
SNMMI Announces Julie Dawn Bolin, MS, CNMT, as President-Elect of the Technologist Section During 2023 Annual Meeting – Jun 25, 2023
Julie Dawn Bolin, MS, CNMT, program director of nuclear medicine technology at GateWay Community College in Phoenix, Arizona, and nuclear medicine technologist at Banner Staffing Servicesin Tucson, Arizona, has been elected 2023-24 president-elect for the SNMMI-TS.
FAPI PET Imaging Accurately Assesses Disease Activity in Rheumatoid Arthritis – Jun 25, 2023
PET imaging with Ga-68 FAPI offers a feasible, reliable, and reproducible method for evaluating disease activity in rheumatoid arthritis, according to new research presented at the 2023 SNMMI Annual Meeting.
SNMMI Announces Dmitry Beyder, CNMT, MPA, as President of the Technologist Section During 2023 Annual Meeting – Jun 25, 2023
Dmitry Beyder, CNMT, MPA, radiology program manager of nuclear medicine, PET, CT and patient transport at Barnes-Jewish Hospital/Mallinckrodt Institute of Radiology in St. Louis, Missouri, has been elected as the 2023-24 president for the SNMMI-TS.
New PET Model for Quantifying Cardiac Amyloidosis Allows for More Accurate Diagnosis and Monitoring – Jun 25, 2023
Researchers have identified the optimal tracer kinetic model to quantify 18F-flutemetamol myocardial uptake in patients with transthyretin (ATTR) cardiac amyloidosis.
SNMMI Abstract of the Year: Novel Molecularly Targeted I-131 Apamistamab Enables Marrow Transplantation with Long-term Survival in Relapsed/Refractory Acute Myeloid Leukemia – Jun 25, 2023
Personalized dosing of Iomab-B (I-131 apamistamab), has been shown to successfully enable relapsed and/or refractory acute myeloid leukemia (AML) patients with active disease to successfully receive potentially life-saving bone marrow transplantation.
New Whole-Body PET Technology Offers Cost-Effective Solution to Improve Image Resolution and Sensitivity – Jun 24, 2023
A newly developed technology called augmented whole-body scanning via magnifying PET (AWSM-PET) has been shown to enhance the image resolution and system sensitivity of clinical whole-body PET/CT imaging.
Ultra-High Resolution Brain PET Scanner Visualizes and Quantifies Brainstem Nuclei for the First Time – Jun 24, 2023
A new ultra-high resolution (UHR) brain PET scanner may have the ability to characterize previously indistinguishable brain regions that are known to be involved in Alzheimers disease, depressive disorders, visual attention disorders, tinnitus, and other conditions.
Nuclear Medicine Global Initiative Reports Worldwide Challenges and Opportunities in Theranostics Education – Jun 23, 2023
Leaders from 12 nuclear medicine organizations around the world have issued a white paper about the challenges and opportunities in theranostics education.
Pretherapy Imaging and Dosimetry Offer Personalized Treatment Planning for Thyroid Cancer Patients – Jun 22, 2023
JNM: A combination of pretherapy imaging and dosimetry can help ensure that patients with refractory differentiated thyroid cancer obtain the maximum benefit from radioactive iodine treatments following redifferentiation therapy.

Displaying 61 to 70 of 199 records
Page: << Prev 4… 5… 6… 7… 8… 9… 10… Next >>